アルファサラセミア治療の世界市場インサイト、2030年までの予測Global Alpha Thalassemia Treatment Market Insights, Forecast to 2030 αグロビン鎖の欠損または欠失によるαサラセミアは、一般的な血液学的所見では無症状であり、サイレントキャリアの状態になる。 市場分析と洞察:アルファサラセミア治療の世界市場 世界のアルファサラセミア治... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリーαグロビン鎖の欠損または欠失によるαサラセミアは、一般的な血液学的所見では無症状であり、サイレントキャリアの状態になる。市場分析と洞察:アルファサラセミア治療の世界市場 世界のアルファサラセミア治療市場は、予測期間中に年平均成長率(CAGR)%で、2024年の100万米ドルから2030年には100万米ドルに成長すると予測されています。 世界の医薬品市場は2022年に1,475億米ドルで、今後6年間のCAGRは5%で成長する。医薬品市場には化学医薬品と生物学的製剤が含まれる。生物学的製剤は2022年に3810億ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間&政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要とする患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の流行はワクチン開発とサプライチェーン・マネジメントの重要性を浮き彫りにし、製薬企業が新たな公衆衛生のニーズに機敏に対応する必要性をさらに強調している。 レポートの対象 本レポートでは、アルファサラセミア治療薬の世界市場規模を概観します。2019年~2023年の過去の市場収益データ、2024年の推定値、2030年までのCAGR予測による世界市場動向の分析。 アルファ型サラセミア治療薬の主要生産者を調査し、主要地域・国の収益も掲載しています。アルファ型サラセミア治療薬の今後の市場ポテンシャルと、この市場を様々なセグメントとサブセグメントに予測するための主要地域/国の注目点のハイライト。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。 本レポートは、2019年から2024年までのデータ、主要企業のアルファ型サラセミア治療収益、市場シェア、業界ランキングに焦点を当てています。世界のアルファ型サラセミア治療市場における主要な利害関係者を特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争環境を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。 本レポートでは、2019年から2030年までのタイプ別、用途別のセグメントデータ、収益、成長率を分析しています。アルファ型サラセミア治療の収益、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。 市場区分 企業別 グラクソ・スミスクライン ノバルティスAG ベリカム・ファーマシューティカルズ アクセロン・ファーマ ジョンソン・エンド・ジョンソン メルク社 ギリアド・サイエンシズ タイプ別セグメント 葉酸 デフェラシロクス デフェリプロン ヒドロキシ尿素 用途別セグメント 病院 外来手術センター その他 地域別 北米 米国 カナダ 欧州 ドイツ フランス 英国 イタリア ロシア 北欧諸国 その他の欧州諸国 中国 アジア(中国を除く) 日本 韓国 中国 台湾 東南アジア インド ラテンアメリカ、中東、アフリカ ブラジル メキシコ トルコ イスラエル GCC諸国 各章の概要 第1章:報告書のスコープ、各市場セグメント(製品タイプ、用途など)の市場規模、将来の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的な展開の可能性について、ハイレベルな見解を提供しています。 第2章 アルファサラセミア治療薬の世界・地域レベルでの収益各地域とその主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、生産能力などを紹介しています。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界各社が直面する課題とリスク、業界の関連政策の分析などを紹介しています。 第3章:アルファ型サラセミア治療薬企業の競争環境、収益、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析。 第4章:読者が異なる市場セグメントにおけるブルーオーシャン市場を見つけるのを助けるために、各市場セグメントの収益、発展の可能性をカバーし、タイプ別に様々な市場セグメントの分析を提供します。 第5章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの収益、発展の可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。 第6章:北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の収益。 第7章:ヨーロッパ:タイプ別、用途別、国別、セグメント別収益。 第8章:中国:タイプ別、用途別、セグメント別収益。 第9章:アジア(中国を除く):タイプ別、用途別、地域別、各セグメントの収益。 第10章:中東、アフリカ、ラテンアメリカ:タイプ別、用途別、国別、セグメント別収益。 第11章:主要企業のプロフィールを提供し、製品の説明や仕様、アルファサラセミア治療の収益、売上総利益率、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介する。 第12章:アナリストの視点/結論 目次1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Alpha Thalassemia Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 1.2.2 Folic Acid 1.2.3 Deferasirox 1.2.4 Deferiprone 1.2.5 Hydroxyurea 1.3 Market by Application 1.3.1 Global Alpha Thalassemia Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 1.3.2 Hospitals 1.3.3 Ambulatory Surgical Centers 1.3.4 Others 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Alpha Thalassemia Treatment Market Perspective (2019-2030) 2.2 Global Alpha Thalassemia Treatment Growth Trends by Region 2.2.1 Alpha Thalassemia Treatment Market Size by Region: 2019 VS 2023 VS 2030 2.2.2 Alpha Thalassemia Treatment Historic Market Size by Region (2019-2024) 2.2.3 Alpha Thalassemia Treatment Forecasted Market Size by Region (2025-2030) 2.3 Alpha Thalassemia Treatment Market Dynamics 2.3.1 Alpha Thalassemia Treatment Industry Trends 2.3.2 Alpha Thalassemia Treatment Market Drivers 2.3.3 Alpha Thalassemia Treatment Market Challenges 2.3.4 Alpha Thalassemia Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Revenue Alpha Thalassemia Treatment by Players 3.1.1 Global Alpha Thalassemia Treatment Revenue by Players (2019-2024) 3.1.2 Global Alpha Thalassemia Treatment Revenue Market Share by Players (2019-2024) 3.2 Global Alpha Thalassemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Global Key Players of Alpha Thalassemia Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024 3.4 Global Alpha Thalassemia Treatment Market Concentration Ratio 3.4.1 Global Alpha Thalassemia Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Alpha Thalassemia Treatment Revenue in 2023 3.5 Global Key Players of Alpha Thalassemia Treatment Head office and Area Served 3.6 Global Key Players of Alpha Thalassemia Treatment, Product and Application 3.7 Global Key Players of Alpha Thalassemia Treatment, Date of Enter into This Industry 3.8 Mergers & Acquisitions, Expansion Plans 4 Alpha Thalassemia Treatment Breakdown Data by Type 4.1 Global Alpha Thalassemia Treatment Historic Market Size by Type (2019-2024) 4.2 Global Alpha Thalassemia Treatment Forecasted Market Size by Type (2025-2030) 5 Alpha Thalassemia Treatment Breakdown Data by Application 5.1 Global Alpha Thalassemia Treatment Historic Market Size by Application (2019-2024) 5.2 Global Alpha Thalassemia Treatment Forecasted Market Size by Application (2025-2030) 6 North America 6.1 North America Alpha Thalassemia Treatment Market Size (2019-2030) 6.2 North America Alpha Thalassemia Treatment Market Size by Type 6.2.1 North America Alpha Thalassemia Treatment Market Size by Type (2019-2024) 6.2.2 North America Alpha Thalassemia Treatment Market Size by Type (2025-2030) 6.2.3 North America Alpha Thalassemia Treatment Market Share by Type (2019-2030) 6.3 North America Alpha Thalassemia Treatment Market Size by Application 6.3.1 North America Alpha Thalassemia Treatment Market Size by Application (2019-2024) 6.3.2 North America Alpha Thalassemia Treatment Market Size by Application (2025-2030) 6.3.3 North America Alpha Thalassemia Treatment Market Share by Application (2019-2030) 6.4 North America Alpha Thalassemia Treatment Market Size by Country 6.4.1 North America Alpha Thalassemia Treatment Market Size by Country: 2019 VS 2023 VS 2030 6.4.2 North America Alpha Thalassemia Treatment Market Size by Country (2019-2024) 6.4.3 North America Alpha Thalassemia Treatment Market Size by Country (2025-2030) 6.4.4 U.S. 6.4.5 Canada 7 Europe 7.1 Europe Alpha Thalassemia Treatment Market Size (2019-2030) 7.2 Europe Alpha Thalassemia Treatment Market Size by Type 7.2.1 Europe Alpha Thalassemia Treatment Market Size by Type (2019-2024) 7.2.2 Europe Alpha Thalassemia Treatment Market Size by Type (2025-2030) 7.2.3 Europe Alpha Thalassemia Treatment Market Share by Type (2019-2030) 7.3 Europe Alpha Thalassemia Treatment Market Size by Application 7.3.1 Europe Alpha Thalassemia Treatment Market Size by Application (2019-2024) 7.3.2 Europe Alpha Thalassemia Treatment Market Size by Application (2025-2030) 7.3.3 Europe Alpha Thalassemia Treatment Market Share by Application (2019-2030) 7.4 Europe Alpha Thalassemia Treatment Market Size by Country 7.4.1 Europe Alpha Thalassemia Treatment Market Size by Country: 2019 VS 2023 VS 2030 7.4.2 Europe Alpha Thalassemia Treatment Market Size by Country (2019-2024) 7.4.3 Europe Alpha Thalassemia Treatment Market Size by Country (2025-2030) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 China 8.1 China Alpha Thalassemia Treatment Market Size (2019-2030) 8.2 China Alpha Thalassemia Treatment Market Size by Type 8.2.1 China Alpha Thalassemia Treatment Market Size by Type (2019-2024) 8.2.2 China Alpha Thalassemia Treatment Market Size by Type (2025-2030) 8.2.3 China Alpha Thalassemia Treatment Market Share by Type (2019-2030) 8.3 China Alpha Thalassemia Treatment Market Size by Application 8.3.1 China Alpha Thalassemia Treatment Market Size by Application (2019-2024) 8.3.2 China Alpha Thalassemia Treatment Market Size by Application (2025-2030) 8.3.3 China Alpha Thalassemia Treatment Market Share by Application (2019-2030) 9 Asia (excluding China) 9.1 Asia Alpha Thalassemia Treatment Market Size (2019-2030) 9.2 Asia Alpha Thalassemia Treatment Market Size by Type 9.2.1 Asia Alpha Thalassemia Treatment Market Size by Type (2019-2024) 9.2.2 Asia Alpha Thalassemia Treatment Market Size by Type (2025-2030) 9.2.3 Asia Alpha Thalassemia Treatment Market Share by Type (2019-2030) 9.3 Asia Alpha Thalassemia Treatment Market Size by Application 9.3.1 Asia Alpha Thalassemia Treatment Market Size by Application (2019-2024) 9.3.2 Asia Alpha Thalassemia Treatment Market Size by Application (2025-2030) 9.3.3 Asia Alpha Thalassemia Treatment Market Share by Application (2019-2030) 9.4 Asia Alpha Thalassemia Treatment Market Size by Region 9.4.1 Asia Alpha Thalassemia Treatment Market Size by Region: 2019 VS 2023 VS 2030 9.4.2 Asia Alpha Thalassemia Treatment Market Size by Region (2019-2024) 9.4.3 Asia Alpha Thalassemia Treatment Market Size by Region (2025-2030) 9.4.4 Japan 9.4.5 South Korea 9.4.6 China Taiwan 9.4.7 Southeast Asia 9.4.8 India 9.4.9 Australia 10 Middle East, Africa, and Latin America 10.1 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size (2019-2030) 10.2 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size by Type 10.2.1 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size by Type (2019-2024) 10.2.2 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size by Type (2025-2030) 10.2.3 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Share by Type (2019-2030) 10.3 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size by Application 10.3.1 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size by Application (2019-2024) 10.3.2 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size by Application (2025-2030) 10.3.3 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Share by Application (2019-2030) 10.4 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size by Country 10.4.1 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size by Country: 2019 VS 2023 VS 2030 10.4.2 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size by Country (2019-2024) 10.4.3 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size by Country (2025-2030) 10.4.4 Brazil 10.4.5 Mexico 10.4.6 Turkey 10.4.7 Saudi Arabia 10.4.8 Israel 10.4.9 GCC Countries 11 Key Players Profiles 11.1 GlaxoSmithKline 11.1.1 GlaxoSmithKline Company Details 11.1.2 GlaxoSmithKline Business Overview 11.1.3 GlaxoSmithKline Alpha Thalassemia Treatment Introduction 11.1.4 GlaxoSmithKline Revenue in Alpha Thalassemia Treatment Business (2019-2024) 11.1.5 GlaxoSmithKline Recent Developments 11.2 Novartis AG 11.2.1 Novartis AG Company Details 11.2.2 Novartis AG Business Overview 11.2.3 Novartis AG Alpha Thalassemia Treatment Introduction 11.2.4 Novartis AG Revenue in Alpha Thalassemia Treatment Business (2019-2024) 11.2.5 Novartis AG Recent Developments 11.3 Bellicum Pharmaceuticals 11.3.1 Bellicum Pharmaceuticals Company Details 11.3.2 Bellicum Pharmaceuticals Business Overview 11.3.3 Bellicum Pharmaceuticals Alpha Thalassemia Treatment Introduction 11.3.4 Bellicum Pharmaceuticals Revenue in Alpha Thalassemia Treatment Business (2019-2024) 11.3.5 Bellicum Pharmaceuticals Recent Developments 11.4 Acceleron Pharma 11.4.1 Acceleron Pharma Company Details 11.4.2 Acceleron Pharma Business Overview 11.4.3 Acceleron Pharma Alpha Thalassemia Treatment Introduction 11.4.4 Acceleron Pharma Revenue in Alpha Thalassemia Treatment Business (2019-2024) 11.4.5 Acceleron Pharma Recent Developments 11.5 Johnson & Johnson 11.5.1 Johnson & Johnson Company Details 11.5.2 Johnson & Johnson Business Overview 11.5.3 Johnson & Johnson Alpha Thalassemia Treatment Introduction 11.5.4 Johnson & Johnson Revenue in Alpha Thalassemia Treatment Business (2019-2024) 11.5.5 Johnson & Johnson Recent Developments 11.6 Merck & Co. 11.6.1 Merck & Co. Company Details 11.6.2 Merck & Co. Business Overview 11.6.3 Merck & Co. Alpha Thalassemia Treatment Introduction 11.6.4 Merck & Co. Revenue in Alpha Thalassemia Treatment Business (2019-2024) 11.6.5 Merck & Co. Recent Developments 11.7 Gilead Sciences, Inc. 11.7.1 Gilead Sciences, Inc. Company Details 11.7.2 Gilead Sciences, Inc. Business Overview 11.7.3 Gilead Sciences, Inc. Alpha Thalassemia Treatment Introduction 11.7.4 Gilead Sciences, Inc. Revenue in Alpha Thalassemia Treatment Business (2019-2024) 11.7.5 Gilead Sciences, Inc. Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
SummaryAlpha thalassemia causes due to deficiency or absence of alpha globin chains results in alpha thalassemia which is asymptomatic with general hematologic findings and gains silent carrier status. Table of Contents1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Alpha Thalassemia Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 1.2.2 Folic Acid 1.2.3 Deferasirox 1.2.4 Deferiprone 1.2.5 Hydroxyurea 1.3 Market by Application 1.3.1 Global Alpha Thalassemia Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 1.3.2 Hospitals 1.3.3 Ambulatory Surgical Centers 1.3.4 Others 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Alpha Thalassemia Treatment Market Perspective (2019-2030) 2.2 Global Alpha Thalassemia Treatment Growth Trends by Region 2.2.1 Alpha Thalassemia Treatment Market Size by Region: 2019 VS 2023 VS 2030 2.2.2 Alpha Thalassemia Treatment Historic Market Size by Region (2019-2024) 2.2.3 Alpha Thalassemia Treatment Forecasted Market Size by Region (2025-2030) 2.3 Alpha Thalassemia Treatment Market Dynamics 2.3.1 Alpha Thalassemia Treatment Industry Trends 2.3.2 Alpha Thalassemia Treatment Market Drivers 2.3.3 Alpha Thalassemia Treatment Market Challenges 2.3.4 Alpha Thalassemia Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Revenue Alpha Thalassemia Treatment by Players 3.1.1 Global Alpha Thalassemia Treatment Revenue by Players (2019-2024) 3.1.2 Global Alpha Thalassemia Treatment Revenue Market Share by Players (2019-2024) 3.2 Global Alpha Thalassemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Global Key Players of Alpha Thalassemia Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024 3.4 Global Alpha Thalassemia Treatment Market Concentration Ratio 3.4.1 Global Alpha Thalassemia Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Alpha Thalassemia Treatment Revenue in 2023 3.5 Global Key Players of Alpha Thalassemia Treatment Head office and Area Served 3.6 Global Key Players of Alpha Thalassemia Treatment, Product and Application 3.7 Global Key Players of Alpha Thalassemia Treatment, Date of Enter into This Industry 3.8 Mergers & Acquisitions, Expansion Plans 4 Alpha Thalassemia Treatment Breakdown Data by Type 4.1 Global Alpha Thalassemia Treatment Historic Market Size by Type (2019-2024) 4.2 Global Alpha Thalassemia Treatment Forecasted Market Size by Type (2025-2030) 5 Alpha Thalassemia Treatment Breakdown Data by Application 5.1 Global Alpha Thalassemia Treatment Historic Market Size by Application (2019-2024) 5.2 Global Alpha Thalassemia Treatment Forecasted Market Size by Application (2025-2030) 6 North America 6.1 North America Alpha Thalassemia Treatment Market Size (2019-2030) 6.2 North America Alpha Thalassemia Treatment Market Size by Type 6.2.1 North America Alpha Thalassemia Treatment Market Size by Type (2019-2024) 6.2.2 North America Alpha Thalassemia Treatment Market Size by Type (2025-2030) 6.2.3 North America Alpha Thalassemia Treatment Market Share by Type (2019-2030) 6.3 North America Alpha Thalassemia Treatment Market Size by Application 6.3.1 North America Alpha Thalassemia Treatment Market Size by Application (2019-2024) 6.3.2 North America Alpha Thalassemia Treatment Market Size by Application (2025-2030) 6.3.3 North America Alpha Thalassemia Treatment Market Share by Application (2019-2030) 6.4 North America Alpha Thalassemia Treatment Market Size by Country 6.4.1 North America Alpha Thalassemia Treatment Market Size by Country: 2019 VS 2023 VS 2030 6.4.2 North America Alpha Thalassemia Treatment Market Size by Country (2019-2024) 6.4.3 North America Alpha Thalassemia Treatment Market Size by Country (2025-2030) 6.4.4 U.S. 6.4.5 Canada 7 Europe 7.1 Europe Alpha Thalassemia Treatment Market Size (2019-2030) 7.2 Europe Alpha Thalassemia Treatment Market Size by Type 7.2.1 Europe Alpha Thalassemia Treatment Market Size by Type (2019-2024) 7.2.2 Europe Alpha Thalassemia Treatment Market Size by Type (2025-2030) 7.2.3 Europe Alpha Thalassemia Treatment Market Share by Type (2019-2030) 7.3 Europe Alpha Thalassemia Treatment Market Size by Application 7.3.1 Europe Alpha Thalassemia Treatment Market Size by Application (2019-2024) 7.3.2 Europe Alpha Thalassemia Treatment Market Size by Application (2025-2030) 7.3.3 Europe Alpha Thalassemia Treatment Market Share by Application (2019-2030) 7.4 Europe Alpha Thalassemia Treatment Market Size by Country 7.4.1 Europe Alpha Thalassemia Treatment Market Size by Country: 2019 VS 2023 VS 2030 7.4.2 Europe Alpha Thalassemia Treatment Market Size by Country (2019-2024) 7.4.3 Europe Alpha Thalassemia Treatment Market Size by Country (2025-2030) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 China 8.1 China Alpha Thalassemia Treatment Market Size (2019-2030) 8.2 China Alpha Thalassemia Treatment Market Size by Type 8.2.1 China Alpha Thalassemia Treatment Market Size by Type (2019-2024) 8.2.2 China Alpha Thalassemia Treatment Market Size by Type (2025-2030) 8.2.3 China Alpha Thalassemia Treatment Market Share by Type (2019-2030) 8.3 China Alpha Thalassemia Treatment Market Size by Application 8.3.1 China Alpha Thalassemia Treatment Market Size by Application (2019-2024) 8.3.2 China Alpha Thalassemia Treatment Market Size by Application (2025-2030) 8.3.3 China Alpha Thalassemia Treatment Market Share by Application (2019-2030) 9 Asia (excluding China) 9.1 Asia Alpha Thalassemia Treatment Market Size (2019-2030) 9.2 Asia Alpha Thalassemia Treatment Market Size by Type 9.2.1 Asia Alpha Thalassemia Treatment Market Size by Type (2019-2024) 9.2.2 Asia Alpha Thalassemia Treatment Market Size by Type (2025-2030) 9.2.3 Asia Alpha Thalassemia Treatment Market Share by Type (2019-2030) 9.3 Asia Alpha Thalassemia Treatment Market Size by Application 9.3.1 Asia Alpha Thalassemia Treatment Market Size by Application (2019-2024) 9.3.2 Asia Alpha Thalassemia Treatment Market Size by Application (2025-2030) 9.3.3 Asia Alpha Thalassemia Treatment Market Share by Application (2019-2030) 9.4 Asia Alpha Thalassemia Treatment Market Size by Region 9.4.1 Asia Alpha Thalassemia Treatment Market Size by Region: 2019 VS 2023 VS 2030 9.4.2 Asia Alpha Thalassemia Treatment Market Size by Region (2019-2024) 9.4.3 Asia Alpha Thalassemia Treatment Market Size by Region (2025-2030) 9.4.4 Japan 9.4.5 South Korea 9.4.6 China Taiwan 9.4.7 Southeast Asia 9.4.8 India 9.4.9 Australia 10 Middle East, Africa, and Latin America 10.1 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size (2019-2030) 10.2 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size by Type 10.2.1 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size by Type (2019-2024) 10.2.2 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size by Type (2025-2030) 10.2.3 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Share by Type (2019-2030) 10.3 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size by Application 10.3.1 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size by Application (2019-2024) 10.3.2 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size by Application (2025-2030) 10.3.3 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Share by Application (2019-2030) 10.4 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size by Country 10.4.1 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size by Country: 2019 VS 2023 VS 2030 10.4.2 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size by Country (2019-2024) 10.4.3 Middle East, Africa, and Latin America Alpha Thalassemia Treatment Market Size by Country (2025-2030) 10.4.4 Brazil 10.4.5 Mexico 10.4.6 Turkey 10.4.7 Saudi Arabia 10.4.8 Israel 10.4.9 GCC Countries 11 Key Players Profiles 11.1 GlaxoSmithKline 11.1.1 GlaxoSmithKline Company Details 11.1.2 GlaxoSmithKline Business Overview 11.1.3 GlaxoSmithKline Alpha Thalassemia Treatment Introduction 11.1.4 GlaxoSmithKline Revenue in Alpha Thalassemia Treatment Business (2019-2024) 11.1.5 GlaxoSmithKline Recent Developments 11.2 Novartis AG 11.2.1 Novartis AG Company Details 11.2.2 Novartis AG Business Overview 11.2.3 Novartis AG Alpha Thalassemia Treatment Introduction 11.2.4 Novartis AG Revenue in Alpha Thalassemia Treatment Business (2019-2024) 11.2.5 Novartis AG Recent Developments 11.3 Bellicum Pharmaceuticals 11.3.1 Bellicum Pharmaceuticals Company Details 11.3.2 Bellicum Pharmaceuticals Business Overview 11.3.3 Bellicum Pharmaceuticals Alpha Thalassemia Treatment Introduction 11.3.4 Bellicum Pharmaceuticals Revenue in Alpha Thalassemia Treatment Business (2019-2024) 11.3.5 Bellicum Pharmaceuticals Recent Developments 11.4 Acceleron Pharma 11.4.1 Acceleron Pharma Company Details 11.4.2 Acceleron Pharma Business Overview 11.4.3 Acceleron Pharma Alpha Thalassemia Treatment Introduction 11.4.4 Acceleron Pharma Revenue in Alpha Thalassemia Treatment Business (2019-2024) 11.4.5 Acceleron Pharma Recent Developments 11.5 Johnson & Johnson 11.5.1 Johnson & Johnson Company Details 11.5.2 Johnson & Johnson Business Overview 11.5.3 Johnson & Johnson Alpha Thalassemia Treatment Introduction 11.5.4 Johnson & Johnson Revenue in Alpha Thalassemia Treatment Business (2019-2024) 11.5.5 Johnson & Johnson Recent Developments 11.6 Merck & Co. 11.6.1 Merck & Co. Company Details 11.6.2 Merck & Co. Business Overview 11.6.3 Merck & Co. Alpha Thalassemia Treatment Introduction 11.6.4 Merck & Co. Revenue in Alpha Thalassemia Treatment Business (2019-2024) 11.6.5 Merck & Co. Recent Developments 11.7 Gilead Sciences, Inc. 11.7.1 Gilead Sciences, Inc. Company Details 11.7.2 Gilead Sciences, Inc. Business Overview 11.7.3 Gilead Sciences, Inc. Alpha Thalassemia Treatment Introduction 11.7.4 Gilead Sciences, Inc. Revenue in Alpha Thalassemia Treatment Business (2019-2024) 11.7.5 Gilead Sciences, Inc. Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
QYResearch社の医療分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |